Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 38
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Neurobiol Dis ; : 106526, 2024 May 09.
Artigo em Inglês | MEDLINE | ID: mdl-38734152

RESUMO

Alzheimer's disease (AD) is a multifactorial neurodegenerative disease with a complex origin, thought to involve a combination of genetic, biological and environmental factors. Insulin dysfunction has emerged as a potential factor contributing to AD pathogenesis, particularly in individuals with diabetes, and among those with insulin deficiency or undergoing insulin therapy. The intraperitoneal administration of streptozotocin (STZ) is a widely used rodent model to explore the impact of insulin deficiency on AD pathology, although prior research predominantly focused on young animals, with no comparative analysis across different age groups. Our study aimed to fill this gap by analyzing the impact of insulin dysfunction in 7 and 23 months 3xTg-AD mice, that exhibit both amyloid and tau pathologies. Our objective was to elucidate the age-specific consequences of insulin deficiency on AD pathology. STZ administration led to insulin deficiency in the younger mice, resulting in an increase in cortical amyloid-ß (Aß) and tau aggregation, while tau phosphorylation was not significantly affected. Conversely, older mice displayed an unexpected resilience to the peripheral metabolic impact of STZ, while exhibiting an increase in both tau phosphorylation and aggregation without significantly affecting amyloid pathology. These changes were paralleled with alterations in signaling pathways involving tau kinases and phosphatases. Several markers of blood-brain barrier (BBB) integrity declined with age in 3xTg-AD mice, which might facilitate a direct neurotoxic effect of STZ in older mice. Overall, our research confirms the influence of insulin signaling dysfunction on AD pathology, but also advises careful interpretation of data related to STZ-induced effects in older animals.

2.
Methods Mol Biol ; 2754: 323-341, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38512674

RESUMO

The intracellular accumulation of microtubule-associated protein tau is a characteristic feature of tauopathies, a group of neurodegenerative diseases including Alzheimer's disease. Formation of insoluble tau aggregates is initiated by the abnormal hyperphosphorylation and oligomerization of tau. Over the past decades, multiple transgenic rodent models mimicking tauopathies have been develop, showcasing this neuropathological hallmark. The biochemical analysis of insoluble tau in these models has served as a valuable tool to understand the progression of tau-related pathology. In this chapter, we provide a comprehensive review of the two primary methods for isolating insoluble tau, namely, sarkosyl and formic acid extraction (and their variants), which are employed for biochemical analysis in transgenic mouse models of tauopathy. We also analyze the strengths and limitations of these methods.


Assuntos
Doença de Alzheimer , Tauopatias , Camundongos , Animais , Roedores/metabolismo , Modelos Animais de Doenças , Tauopatias/metabolismo , Proteínas tau/genética , Proteínas tau/metabolismo , Doença de Alzheimer/metabolismo , Camundongos Transgênicos , Encéfalo/metabolismo
3.
J Anim Sci ; 1022024 Jan 03.
Artigo em Inglês | MEDLINE | ID: mdl-38141243

RESUMO

In dairy goat kids, weaning is often associated with poor growth leading to a decline in welfare and performance; however, little is known about optimal weaning practices. This study aimed to determine the optimal weaning age for dairy goat kids to maximize outcome measures of welfare related to growth, feed intake, and behavior. Thirty-six newborn female Alpine kids were blocked by weight and birth date, paired with a similar male companion and randomly allocated to one of the three weaning age treatments: 6 (6W), 8 (8W), and 10 wk (10W). Kids had ad libitum access to acidified milk replacer refilled twice daily, concentrates, hay, and water. Milk consumption was measured daily, and concentrate consumption, weekly. Ten behaviors were live observed on days -8, -4, 0, 6, and 12 relative to weaning (i.e., weaning day = 0). Kruskal-Wallis tests were used to assess differences from baseline between the 6W, 8W, and 10W treatments. Post hoc analysis using the Dwass, Steel, Critchlow-Fligner (DSCF) multiple comparison analysis was used to evaluate pairwise treatment differences based on two-sample Wilcoxon comparisons. Kids weaned at 10 wk had the greatest increase compared to baseline in concentrate consumption (P = 0.0160), and greatest decrease compared to baseline in vocalization (P = 0.0008) while both 8- and 10- wk kid's groups had the greatest increase compared to baseline in self-grooming time (P < 0.0001), and cross-sucking time (P = 0.0006). Kids weaned at 6 wk of age were found to have the smallest increase compared to baseline in concentrate consumption (P = 0.0160) and self-grooming time (P < 0.0001), and the greatest increase compared to baseline in allogrooming time (P = 0.0032) and in redirected behaviors aimed towards the environment (biting and licking time [P = 0.0173]; displacement at the nipple frequency [P = 0.0236]). No negative impact of weaning on growth of either group was identified. Overall, our results tend towards a higher degree of discomfort behaviors (allogrooming, biting/licking, displacement, and vocalizations) in kids weaned earlier compared to later weaning, while kids weaned later showed higher levels of positive behaviors (lying time and self-grooming).


In dairy goat kids, there is limited literature available on weaning management practices, despite this period being one of the most stressful events for kids and being associated with measures of poor welfare. This study aimed to compare weaning of dairy goat kids at 6-, 8-, and 10-wk of age to maximize outcome measures of welfare related to growth, feed intake, and behavior. Kids weaned at 10 wk of age had the greatest increase in concentrate consumption and decrease in vocalization. Both 8- and 10-wk kids had the greatest increase in self-grooming and cross-sucking. Kids weaned at 6-wk of age had the smallest increase in concentrate consumption, greatest decrease in self-grooming, and greatest increase in allogrooming and redirected behaviors aimed towards the environment. No negative impact of weaning on growth was identified. Our results showed a higher degree of discomfort behaviors in kids weaned earlier compared to later weaning at 8- or 10-wk. Despite similar levels of discomfort behaviors for kids weaned at later ages, vocalization difference was greatest for kids weaned at 8 wk of age. Kids weaned at later ages seem to cope better with the transition to solid feed compared to kids weaned at an early age.


Assuntos
Ração Animal , Dieta , Feminino , Masculino , Animais , Desmame , Dieta/veterinária , Ração Animal/análise , Ingestão de Alimentos , Leite , Cabras
4.
Poult Sci ; 102(4): 102544, 2023 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-36867921

RESUMO

This study evaluated effects of feeding low-bush wild blueberry (LBP) and organic American cranberry (CRP) pomaces without or with multienzyme supplement (ENZ) on growth performance, organ weight and plasma metabolites in broiler chickens. Nonenzyme-fed (no-ENZ: n = 1,575) and enzyme-fed (ENZ: n = 1,575) day-old male Cobb500 broilers were placed in floor pens (45 chicks/pen) and allocated to five corn-soybean meal-based diets: a basal diet supplemented with either bacitracin methylene disalicylate (BMD, 55 mg/kg), 0.5 or 1% of CRP or LBP in a 2 × 5 factorial design for 35-day experiment. Body weight (BW), feed intake (FI) and mortality were recorded whereas BW gain (BWG) and feed conversion ratio (FCR) were calculated. Birds were sampled at days 21 and 35 for organ weights and plasma metabolites. There were no interactions between diet and ENZ on any parameter (P > 0.05) and no effect of ENZ on overall (d 0-35) growth performance and organ weights (P > 0.05). Birds fed BMD were heavier (P < 0.05) at d 35 and had better overall FCR than berry-supplemented birds. Birds fed 1% LBP had poor FCR than birds fed 0.5% CRP. Birds fed LBP exhibited heavier liver (P < 0.05) than birds fed BMD or 1% CRP. The highest plasma concentrations of aspartate transaminase (AST), creatine kinase (CK) at d 28 and gamma-glutamyl transferase (GGT) at d 35 were found in ENZ-fed birds (P < 0.05). At d 28, birds fed 0.5% LBP showed higher plasma AST and CK concentrations (P < 0.05). However, CRP feeding resulted in a lower plasma CK level compared with BMD feeding (P < 0.05). The lowest cholesterol level was detected in 1% CRP-fed birds. In conclusion, this study showed no ENZ effects to potentiate berry pomaces on the overall growth performance of broilers (P < 0.05. However, plasma profiles revealed the potential of ENZ to modulate the metabolism of pomace-fed broilers. LBP increased BW during the starter phase, while CRP increased BW during the grower phase.


Assuntos
Galinhas , Zea mays , Animais , Masculino , Frutas , Tamanho do Órgão , Glycine max , Farinha , Suplementos Nutricionais/análise , Dieta/veterinária , Ração Animal/análise , Fenômenos Fisiológicos da Nutrição Animal
5.
J CME ; 12(1): 2154423, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36969486

RESUMO

On 25 July 2022, the Continuing Professional Development (CPD) Special Interest Group of the Association for Medical Education in Europe came together to open up discussions during a live webinar on 'Exploring the Evolution of CPD'. The objective was to bring together global medical educators to consider perspectives of CPD from the role of global lifelong learners, the role of educators and the role of education providers and health regulators. The landscape of CPD is evolving, and the roles of each key player must include specific actions for facilitated change. Delivering competency outcomes-based learning, fit for purpose, to lifelong learners in health will require (1) learner agency, (2) leadership from educators and (3) providers of lifelong learning to come together to improve delivery of CPD that leads to meaningful change in practice care delivery.

6.
J Can Assoc Gastroenterol ; 5(1): 18-24, 2022 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-35118223

RESUMO

BACKGROUND: Competency-based gastrointestinal endoscopy training is concerned with outcomes of the learning experience. Feedback allows for trainees to achieve the expected outcomes. However, little is known about trainees' experience of receiving feedback. Gaining understanding of their experience could help improve feedback practices. The study was conducted to explore what it means for adult gastroenterology trainees to receive feedback on their performance of endoscopy in the workplace. METHODS: An interpretative phenomenological approach was used. Individual semi-structured interviews were conducted with six trainees from three Canadian adult gastroenterology residency programs. Interviews were audio-recorded and transcribed verbatim for analysis. Analysis was conducted to identify the phenomenological themes across participants' accounts of lived experience to provide an insight into the meaning of experiencing the studied phenomenon. FINDINGS: Three phenomenological themes of experience were identified: taking pauses, negotiating understandings and accepting asymmetry. Taking pauses allowed for participants to receive feedback on their performance of endoscopy. Participants needed to negotiate attending gastroenterologists' different understandings of gastrointestinal endoscopy while carrying their own whenever feedback was provided. They had to accept the asymmetry between the roles of care provider and learner as well. DISCUSSION: The study has captured the uniqueness and the complexity of the lived experience of receiving feedback on the performance of endoscopy in the workplace from the perspective of study participants. The gained understanding of this experience has enabled the authors to suggest how attending gastroenterologists' feedback practices may be improved.

7.
Environ Monit Assess ; 193(11): 740, 2021 Oct 21.
Artigo em Inglês | MEDLINE | ID: mdl-34674037

RESUMO

Honeybees have been used in Europe as environmental bioindicators for heavy metals and polycyclic aromatic hydrocarbons (PAHs). However, their potential has been little explored in North America, especially between environments which have similar pollution levels. Many urban residents and stakeholders are concerned with air quality, mainly in regard to gradients of exposure to industrial pollution between deprived and privileged subpopulation. Thus, the aim of this study was to evaluate the use of honeybees as bioindicators to assess exposure to heavy metals and PAHs in Québec City, Canada, in different socioeconomic districts of Quebec City (deprivation index). Honeybees were sampled over a 5-month period (May to September) at six locations distributed in two urban areas that are distinct geomorphologically and socioeconomically (lower town socio-economically deprived and upper town socioeconomically privileged) and two control rural locations. Six PAHs were analyzed by ultra-performance liquid chromatography (UPLC), while four heavy metals were analyzed by inductively coupled plasma mass spectrometry. Arsenic was the only measured pollutant that showed a significant gradient of exposure between rural and urban environments, but also between the two urban areas. Furthermore, we were able to detect significant differences at certain sampling times for heavy metals and PAHs. Overall, the results show that honeybees are sensitive enough to detect differences between the differential urban environments of a city presumed to have similar pollution levels and therefore could be used when potential socio-environmental inequalities are present.


Assuntos
Monitoramento Biológico , Hidrocarbonetos Policíclicos Aromáticos , Animais , Abelhas , Cidades , Monitoramento Ambiental , Hidrocarbonetos Policíclicos Aromáticos/análise , Fatores Socioeconômicos
8.
Front Immunol ; 12: 621803, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34149685

RESUMO

Feeding practices have been found to influence gut microbiota which play a major role in immunity of poultry. In the present study, changes in cecal microbiota and humoral responses resulting in the 55 ppm bacitracin (BACI), 1% each of cranberry (CP1) and wild blueberry (BP1) pomace alone or in combination (CP+BP) feeding in broiler Cobb 500 vaccinated or not against coccidiosis were investigated. In the non-vaccinated group, no significant treatment effects were observed on performance parameters. Vaccination significantly affected bird's performance parameters particularly during the growing phase from 10 to 20 days of age. In general, the prevalence of coccidiosis and necrotic enteritis (NE) was reduced by vaccination (P < 0.05). BACI-treated birds showed low intestinal lesion scores, and both CP1 and BP1 feed supplementations reduced Eimeria acervulina and Clostridium perfringens incidences similar to BACI. Vaccination induced change in serum enzymes, minerals, and lipid levels in 21-day old birds while, levels of triglyceride (TRIG) and non-esterified fatty acids (NEFA) were higher (P < 0.05) in CP1 treated non-vaccinated group than in the control. The levels of NEFA were lower in BACI- and CP1-fed birds than in the control in non-vaccinated day 28 old birds. The highest levels of all estimated three immunoglobulins (IgY, IgM, and IgA) were found in the vaccinated birds. Metagenomics analysis of the cecal bacterial community in 21-day old birds showed the presence of Firmicutes (90%), Proteobacteria (5%), Actinobacteria (2%), and Bacteroidetes (2%). In the vaccinated group, an effect of BACI was noted on Proteobacteria (P = 0.03). Vaccination and/or dietary treatments influenced the population of Lactobacillaceae, Enterobacteriaceae, Clostridiaceae, and Streptococcaceae which were among the most abundant families. Overall, this study revealed that besides their beneficial effects on performance, alike bacitracin, berry pomaces in poultry feed have profound impacts on the chicken cecal microbiota and blood metabolites that could be influenced by vaccination against coccidiosis.


Assuntos
Infecções Bacterianas/imunologia , Doenças das Aves/imunologia , Ceco/microbiologia , Galinhas/imunologia , Coccídios/fisiologia , Coccidiose/imunologia , Eimeria/fisiologia , Microbioma Gastrointestinal/imunologia , Vacinas Protozoárias/imunologia , Ração Animal , Fenômenos Fisiológicos da Nutrição Animal , Animais , Bacitracina , Mirtilos Azuis (Planta) , Imunidade Humoral , Metabolismo dos Lipídeos , Vacinação , Vaccinium macrocarpon
9.
Acta Neuropathol Commun ; 6(1): 131, 2018 11 29.
Artigo em Inglês | MEDLINE | ID: mdl-30497524

RESUMO

Exposure to the ß-amyloid peptide (Aß) is toxic to neurons and other cell types, but the mechanism(s) involved are still unresolved. Synthetic Aß oligomers can induce ion-permeable pores in synthetic membranes, but whether this ability to damage membranes plays a role in the ability of Aß oligomers to induce tau hyperphosphorylation, or other disease-relevant pathological changes, is unclear. To examine the cellular responses to Aß exposure independent of possible receptor interactions, we have developed an in vivo C. elegans model that allows us to visualize these cellular responses in living animals. We find that feeding C. elegans E. coli expressing human Aß induces a membrane repair response similar to that induced by exposure to the CRY5B, a known pore-forming toxin produced by B. thuringensis. This repair response does not occur when C. elegans is exposed to an Aß Gly37Leu variant, which we have previously shown to be incapable of inducing tau phosphorylation in hippocampal neurons. The repair response is also blocked by loss of calpain function, and is altered by loss-of-function mutations in the C. elegans orthologs of BIN1 and PICALM, well-established risk genes for late onset Alzheimer's disease. To investigate the role of membrane repair on tau phosphorylation directly, we exposed hippocampal neurons to streptolysin O (SLO), a pore-forming toxin that induces a well-characterized membrane repair response. We find that SLO induces tau hyperphosphorylation, which is blocked by calpain inhibition. Finally, we use a novel biarsenical dye-tagging approach to show that the Gly37Leu substitution interferes with Aß multimerization and thus the formation of potentially pore-forming oligomers. We propose that Aß-induced tau hyperphosphorylation may be a downstream consequence of induction of a membrane repair process.


Assuntos
Peptídeos beta-Amiloides/genética , Peptídeos beta-Amiloides/toxicidade , Endossomos/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Fragmentos de Peptídeos/genética , Fragmentos de Peptídeos/toxicidade , Acrilatos/farmacologia , Peptídeos beta-Amiloides/metabolismo , Animais , Animais Geneticamente Modificados , Toxinas de Bacillus thuringiensis , Proteínas de Bactérias/toxicidade , Caenorhabditis elegans , Proteínas de Caenorhabditis elegans/genética , Proteínas de Caenorhabditis elegans/metabolismo , Células Cultivadas , Embrião de Mamíferos , Endossomos/metabolismo , Endotoxinas/toxicidade , Inibidores Enzimáticos/farmacologia , Proteínas Hemolisinas/toxicidade , Hipocampo/citologia , Humanos , Intestinos/citologia , Intestinos/efeitos dos fármacos , Modelos Animais , Morfolinos/farmacologia , Fragmentos de Peptídeos/metabolismo , Fosforilação/efeitos dos fármacos , Ratos , Esfingomielina Fosfodiesterase/farmacologia , Proteínas de Transporte Vesicular/genética , Proteínas de Transporte Vesicular/metabolismo , Cicatrização/efeitos dos fármacos
10.
Synapse ; 72(4)2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29341269

RESUMO

No model fully recapitulates the neuropathology of Alzheimer's disease (AD). Although the triple-transgenic mouse model of AD (3xTg-AD) expresses Aß plaques and tau-laden neurofibrillary tangles, as well as synaptic and behavioral deficits, it does not display frank neuronal loss. Because old age is the most important risk factor in AD, senescence-related interactions might be lacking to truly establish an AD-like environment. To investigate this hypothesis, we bred the 3xTg-AD mouse with the senescence-accelerated mouse prone 8 (SAMP8), a model of accelerated aging. We generated four groups of heterozygous mice with either the SAMP8 or SAMR1 (senescence-resistant-1) genotype, along with either the 3xTg-AD or non-transgenic (NonTg) genotype. Despite no differences among groups in total latency to escape the Barnes maze, a greater number of errors were noticed before entering the target hole in 19-month-old P8/3xTg-AD mice at day 5, compared to other groups. Postmortem analyses revealed increased cortical levels of phospho-tau (Thr231) in female P8/3xTg-AD mice (+277% vs. R1/3xTg-AD mice), without other tau-related changes. Female P8/3xTg-AD mice exhibited higher cortical soluble Aß40 and Aß42 concentrations (Aß40, +85%; Aß42, +35% vs. R1/3xTg-AD), whereas insoluble forms remained unchanged. Higher Aß42 load coincided with increased astroglial activation in female P8/3xTg-AD mice, as measured with glial fibrillary acidic protein (GFAP) (+57% vs. R1/3xTg-AD mice). To probe neuronal degeneration, concentrations of neuronal nuclei (NeuN) were measured, but no differences were detected between groups. Altogether, the SAMP8 genotype had deleterious effects on spatial memory and exerted female-specific aggravation of AD neuropathology without overt neurodegeneration in 3xTg-AD mice.


Assuntos
Doença de Alzheimer , Modelos Animais de Doenças , Camundongos Transgênicos , Doença de Alzheimer/metabolismo , Doença de Alzheimer/patologia , Doença de Alzheimer/psicologia , Peptídeos beta-Amiloides/metabolismo , Precursor de Proteína beta-Amiloide/genética , Precursor de Proteína beta-Amiloide/metabolismo , Animais , Ansiedade/metabolismo , Ansiedade/patologia , Apolipoproteínas E/metabolismo , Peso Corporal/fisiologia , Córtex Cerebral/metabolismo , Córtex Cerebral/patologia , Feminino , Proteína Glial Fibrilar Ácida/metabolismo , Gliose/metabolismo , Gliose/patologia , Humanos , Camundongos da Linhagem 129 , Camundongos Endogâmicos C57BL , Atividade Motora/fisiologia , Fragmentos de Peptídeos/metabolismo , Memória Espacial/fisiologia , Especificidade da Espécie , Proteínas tau/genética , Proteínas tau/metabolismo
11.
Neurobiol Dis ; 98: 1-8, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27793638

RESUMO

Over the last few decades, there has been a significant increase in epidemiological studies suggesting that type 2 diabetes (T2DM) is linked to a higher risk of Alzheimer's disease (AD). However, how T2DM affects AD pathology, such as tau hyperphosphorylation, is not well understood. In this study, we investigated the impact of T2DM on tau phosphorylation in ob/ob mice, a spontaneous genetic model of T2DM. Tau phosphorylation at the AT8 epitope was slightly elevated in 4-week-old ob/ob mice while 26-week-old ob/ob mice exhibited tau hyperphosphorylation at multiple tau phospho-epitopes (Tau1, CP13, AT8, AT180, PHF1). We then examined the mechanism of tau hyperphosphorylation and demonstrated that it is mostly due to hypothermia, as ob/ob mice were hypothermic and normothermia restored tau phosphorylation to control levels. As caffeine has been shown to be beneficial for diabetes, obesity and tau phosphorylation, we, therefore, used it as therapeutic treatment. Unexpectedly, chronic caffeine intake exacerbated tau hyperphosphorylation by promoting deeper hypothermia. Our data indicate that tau hyperphosphorylation is predominately due to hypothermia consequent to impaired thermoregulation in ob/ob mice. This study establishes a novel link between diabetes and AD, and reinforces the importance of recording body temperature to better assess the relationship between diabetes and AD.


Assuntos
Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Hipocampo/metabolismo , Hipotermia/metabolismo , Proteínas tau/metabolismo , Doença de Alzheimer/metabolismo , Animais , Temperatura Corporal/efeitos dos fármacos , Temperatura Corporal/fisiologia , Regulação da Temperatura Corporal/efeitos dos fármacos , Regulação da Temperatura Corporal/fisiologia , Cafeína/toxicidade , Estimulantes do Sistema Nervoso Central/toxicidade , Hipocampo/efeitos dos fármacos , Leptina/administração & dosagem , Leptina/metabolismo , Masculino , Camundongos Endogâmicos C57BL , Camundongos Mutantes , Fosforilação/efeitos dos fármacos , Fosforilação/fisiologia
12.
Hum Mol Genet ; 25(6): 1088-99, 2016 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-26744324

RESUMO

Hereditary spastic paraplegias (HSPs) are a group of neurodegenerative diseases causing progressive gait dysfunction. Over 50 genes have now been associated with HSP. Despite the recent explosion in genetic knowledge, HSP remains without pharmacological treatment. Loss-of-function mutation of the SPAST gene, also known as SPG4, is the most common cause of HSP in patients. SPAST is conserved across animal species and regulates microtubule dynamics. Recent studies have shown that it also modulates endoplasmic reticulum (ER) stress. Here, utilizing null SPAST homologues in C. elegans, Drosophila and zebrafish, we tested FDA-approved compounds known to modulate ER stress in order to ameliorate locomotor phenotypes associated with HSP. We found that locomotor defects found in all of our spastin models could be partially rescued by phenazine, methylene blue, N-acetyl-cysteine, guanabenz and salubrinal. In addition, we show that established biomarkers of ER stress levels correlated with improved locomotor activity upon treatment across model organisms. Our results provide insights into biomarkers and novel therapeutic avenues for HSP.


Assuntos
Modelos Animais de Doenças , Paraplegia Espástica Hereditária/tratamento farmacológico , Adenosina Trifosfatases/genética , Animais , Caenorhabditis elegans , Drosophila , Retículo Endoplasmático/efeitos dos fármacos , Estresse do Retículo Endoplasmático/efeitos dos fármacos , Estresse do Retículo Endoplasmático/genética , Feminino , Humanos , Locomoção/efeitos dos fármacos , Locomoção/genética , Microtúbulos/efeitos dos fármacos , Microtúbulos/metabolismo , Mutação , Fenazinas/farmacologia , Fenótipo , Paraplegia Espástica Hereditária/genética , Peixe-Zebra
13.
Neurobiol Dis ; 88: 55-65, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26777665

RESUMO

Accumulating evidence from epidemiological studies suggest that type 2 diabetes is linked to an increased risk of Alzheimer's disease (AD). However, the consequences of type 2 diabetes on AD pathologies, such as tau hyperphosphorylation, are not well understood. Here, we evaluated the impact of type 2 diabetes on tau phosphorylation in db/db diabetic mice aged 4 and 26weeks. We found increased tau phosphorylation at the CP13 epitope correlating with a deregulation of c-Jun. N-terminal kinase (JNK) and Protein Phosphatase 2A (PP2A) in 4-week-old db/db mice. 26-week-old db/db mice displayed tau hyperphosphorylation at multiple epitopes (CP13, AT8, PHF-1), but no obvious change in kinases or phosphatases, no cleavage of tau, and no deregulation of central insulin signaling pathways. In contrast to younger animals, 26-week-old db/db mice were hypothermic and restoration of normothermia rescued phosphorylation at most epitopes. Our results suggest that, at early stages of type 2 diabetes, changes in tau phosphorylation may be due to deregulation of JNK and PP2A, while at later stages hyperphosphorylation is mostly a consequence of hypothermia. These results provide a novel link between diabetes and tau pathology, and underlie the importance of recording body temperature to better understand the relationship between diabetes and AD.


Assuntos
Envelhecimento/fisiologia , Diabetes Mellitus Tipo 2/terapia , Hipotermia Induzida , Proteínas tau/metabolismo , Análise de Variância , Animais , Glicemia , Peso Corporal/genética , Peso Corporal/fisiologia , Encéfalo/metabolismo , Diabetes Mellitus Tipo 2/genética , Diabetes Mellitus Tipo 2/patologia , Modelos Animais de Doenças , Regulação da Expressão Gênica/genética , Índice Glicêmico , Resistência à Insulina/genética , Leptina/deficiência , Leptina/genética , MAP Quinase Quinase 4/metabolismo , Masculino , Camundongos , Camundongos Mutantes , Fosforilação/genética , Transdução de Sinais/genética
14.
Hum Mol Genet ; 24(1): 86-99, 2015 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-25205109

RESUMO

Huntington's disease (HD) is an autosomal-dominant neurodegenerative disorder caused by polyglutamine expansions in the amino-terminal region of the huntingtin (Htt) protein. At the cellular level, neuronal death is accompanied by the proteolytic cleavage, misfolding and aggregation of huntingtin. Abnormal hyperphosphorylation of tau protein is a characteristic feature of a class of neurodegenerative diseases called tauopathies. As a number of studies have reported tau pathology in HD patients, we investigated whether HD pathology may promote tau hyperphosphorylation and if so tackle some of its underlying mechanisms. For that purpose, we used the R6/2 mouse, a well-characterized model of HD, and analyzed tau phosphorylation before and after the onset of HD-like symptoms. We found a significant increase in tau hyperphosphorylation at the PHF-1 epitope in pre-symptomatic R6/2 mice, whereas symptomatic mice displayed tau hyperphosphorylation at multiple tau phosphoepitopes (AT8, CP13, PT205 and PHF-1). There was no activation of major tau kinases that could explain this observation. However, when we examined tau phosphatases, we found that calcineurin/PP2B was downregulated by 30% in pre-symptomatic and 50% in symptomatic R6/2 mice, respectively. We observed similar changes in tau phosphorylation and calcineurin expression in Q175 mice, another HD model. Calcineurin was also reduced in Q111 compared with Q7 cells. Finally, pharmacological or genetic inhibition of endogenous calcineurin was sufficient to promote tau hyperphosphorylation in neuronal cells. Taken together, our data suggest that mutant huntingtin can induce abnormal tau hyperphosphorylation in vivo, via the deregulation of calcineurin.


Assuntos
Encéfalo/citologia , Calcineurina/metabolismo , Doença de Huntington/metabolismo , Neurônios/metabolismo , Proteínas da Membrana Plasmática de Transporte de Serotonina/genética , Proteínas tau/metabolismo , Animais , Encéfalo/metabolismo , Linhagem Celular , Modelos Animais de Doenças , Regulação da Expressão Gênica , Humanos , Doença de Huntington/genética , Camundongos , Camundongos Transgênicos , Fosforilação
15.
Sci Rep ; 3: 1388, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24045785

RESUMO

Several anesthetics have been reported to suppress the transcription of a number of genes, including Arc, also known as Arg3.1, an immediate early gene that plays a significant role in memory consolidation. The purpose of this study was to explore the mechanism of anesthesia-mediated depression in Arc gene and protein expression. Here, we demonstrate that isoflurane or propofol anesthesia decreases hippocampal Arc protein expression in rats and mice. Surprisingly, this change was secondary to anesthesia-induced hypothermia. Furthermore, we confirm in vivo and in vitro that hypothermia per se is directly responsible for decreased Arc protein levels. This effect was the result of the decline of Arc mRNA basal levels following inhibition of ERK/MAPK by hypothermia. Overall, our results suggest that anesthesia-induced hypothermia leads to ERK inhibition, which in turns decreases Arc levels. These data give new mechanistic insights on the regulation of immediate early genes by anesthesia and hypothermia.


Assuntos
Anestesia , Proteínas do Citoesqueleto/genética , Proteínas do Citoesqueleto/metabolismo , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Regulação da Expressão Gênica , Hipotermia Induzida , Proteínas do Tecido Nervoso/genética , Proteínas do Tecido Nervoso/metabolismo , Anestésicos Inalatórios/farmacologia , Animais , Linhagem Celular , Quinase do Fator 2 de Elongação/metabolismo , Ativação Enzimática/efeitos dos fármacos , Deleção de Genes , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Isoflurano/farmacologia , MAP Quinase Quinase 4/genética , MAP Quinase Quinase 4/metabolismo , Masculino , Camundongos , Ratos , Transdução de Sinais , Transcrição Gênica
16.
Neurobiol Aging ; 34(9): 2175-82, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23591130

RESUMO

In simple systems, lifespan can be extended by various methods including dietary restriction, mutations in the insulin/insulin-like growth factor (IGF) pathway or mitochondria among other processes. It is widely held that the mechanisms that extend lifespan may be adapted for diminishing age-associated pathologies. We tested whether a number of compounds reported to extend lifespan in C. elegans could reduce age-dependent toxicity caused by mutant TAR DNA-binding protein-43 in C. elegans motor neurons. Only half of the compounds tested show protective properties against neurodegeneration, suggesting that extended lifespan is not a strong predictor for neuroprotective properties. We report here that resveratrol, rolipram, reserpine, trolox, propyl gallate, and ethosuximide protect against mutant TAR DNA-binding protein-43 neuronal toxicity. Finally, of all the compounds tested, only resveratrol required daf-16 and sir-2.1 for protection, and ethosuximide showed dependence on daf-16 for its activity.


Assuntos
Envelhecimento/genética , Envelhecimento/fisiologia , Caenorhabditis elegans/genética , Caenorhabditis elegans/fisiologia , Cromanos/farmacologia , Proteínas de Ligação a DNA/antagonistas & inibidores , Proteínas de Ligação a DNA/toxicidade , Etossuximida/farmacocinética , Longevidade/efeitos dos fármacos , Longevidade/genética , Neurônios Motores/efeitos dos fármacos , Fármacos Neuroprotetores , Galato de Propila/farmacologia , Reserpina/farmacologia , Rolipram/farmacologia , Estilbenos/farmacologia , Animais , Resveratrol
17.
Neurobiol Dis ; 55: 64-75, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23567652

RESUMO

C. elegans and D. rerio expressing mutant TAR DNA Binding Protein 43 (TDP-43) are powerful in vivo animal models for the genetics and pharmacology of amyotrophic lateral sclerosis (ALS). Using these small-animal models of ALS, we previously identified methylene blue (MB) as a potent suppressor of TDP-43 toxicity. Consequently here we investigated how MB might exert its neuroprotective properties and found that it acts through reduction of the endoplasmic reticulum (ER) stress response. We tested other compounds known to be active in the ER unfolded protein response in worms and zebrafish expressing mutant human TDP-43 (mTDP-43). We identified three compounds: salubrinal, guanabenz and a new structurally related compound phenazine, which also reduced paralysis, neurodegeneration and oxidative stress in our mTDP-43 models. Using C. elegans genetics, we showed that all four compounds act as potent suppressors of mTDP-43 toxicity through reduction of the ER stress response. Interestingly, these compounds operate through different branches of the ER unfolded protein pathway to achieve a common neuroprotective action. Our results indicate that protein-folding homeostasis in the ER is an important target for therapeutic development in ALS and other TDP-43-related neurodegenerative diseases.


Assuntos
Proteínas de Ligação a DNA/metabolismo , Estresse do Retículo Endoplasmático/genética , Síndromes Neurotóxicas/genética , Síndromes Neurotóxicas/fisiopatologia , Análise de Variância , Animais , Animais Geneticamente Modificados , Caenorhabditis elegans , Proteínas de Caenorhabditis elegans/genética , Cinamatos/farmacologia , Cinamatos/uso terapêutico , Proteínas de Ligação a DNA/genética , Modelos Animais de Doenças , Estresse do Retículo Endoplasmático/efeitos dos fármacos , Reação de Fuga/efeitos dos fármacos , Reação de Fuga/fisiologia , Proteínas de Fluorescência Verde/genética , Proteínas de Fluorescência Verde/metabolismo , Guanabenzo/farmacologia , Guanabenzo/uso terapêutico , Humanos , Microinjeções , Transtornos dos Movimentos/tratamento farmacológico , Transtornos dos Movimentos/etiologia , Mutação/genética , Neurônios/efeitos dos fármacos , Neurônios/patologia , Síndromes Neurotóxicas/tratamento farmacológico , Síndromes Neurotóxicas/patologia , Fenazinas , RNA Mensageiro/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Tioureia/análogos & derivados , Tioureia/farmacologia , Tioureia/uso terapêutico , Fatores de Tempo , Tato/fisiologia , Peixe-Zebra , Proteínas de Peixe-Zebra/genética
18.
Diabetes ; 62(2): 609-17, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22961084

RESUMO

The histopathological hallmarks of Alzheimer disease (AD) include intraneuronal neurofibrillary tangles composed of abnormally hyperphosphorylated τ protein. Insulin dysfunction might influence AD pathology, as population-based and cohort studies have detected higher AD incidence rates in diabetic patients. But how diabetes affects τ pathology is not fully understood. In this study, we investigated the impact of insulin dysfunction on τ phosphorylation in a genetic model of spontaneous type 1 diabetes: the nonobese diabetic (NOD) mouse. Brains of young and adult female NOD mice were examined, but young NOD mice did not display τ hyperphosphorylation. τ phosphorylation at τ-1 and pS422 epitopes was slightly increased in nondiabetic adult NOD mice. At the onset of diabetes, τ was hyperphosphorylated at the τ-1, AT8, CP13, pS262, and pS422. A subpopulation of diabetic NOD mice became hypothermic, and τ hyperphosphorylation further extended to paired helical filament-1 and TG3 epitopes. Furthermore, elevated τ phosphorylation correlated with an inhibition of protein phosphatase 2A (PP2A) activity. Our data indicate that insulin dysfunction in NOD mice leads to AD-like τ hyperphosphorylation in the brain, with molecular mechanisms likely involving a deregulation of PP2A. This model may be a useful tool to address further mechanistic association between insulin dysfunction and AD pathology.


Assuntos
Diabetes Mellitus Tipo 1/metabolismo , Proteína Fosfatase 2/metabolismo , Proteínas tau/metabolismo , Doença de Alzheimer/metabolismo , Animais , Encéfalo/metabolismo , Química Encefálica , Modelos Animais de Doenças , Feminino , Hipotermia , Camundongos , Camundongos Endogâmicos NOD , Emaranhados Neurofibrilares/metabolismo , Fosforilação , Isoformas de Proteínas/metabolismo
19.
PLoS One ; 7(9): e46111, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23029404

RESUMO

Besides memory deficits, Alzheimer's disease (AD) patients suffer from neuropsychiatric symptoms, including alterations in social interactions, which are subject of a growing number of investigations in transgenic models of AD. Yet the biological mechanisms underlying these behavioural alterations are poorly understood. Here, a social interaction paradigm was used to assess social dysfunction in the triple-transgenic mouse model of AD (3xTg-AD). We observed that transgenic mice displayed dimorphic behavioural abnormalities at different ages. Social disinhibition was observed in 18 months old 3xTg-AD males compared to age and sex-matched control mice. In 3xTg-AD females, social disinhibition was present at 12 months followed by reduced social interactions at 18 months. These dimorphic behavioural alterations were not associated with alterations in AD neuropathological markers such as Aß or tau levels in the frontal cortex. However, patch-clamp recordings revealed that enhanced social interactions coincided temporally with an increase in both excitatory and inhibitory basal synaptic inputs to layer 2-3 pyramidal neurons in the prefrontal cortex. These findings uncover a novel pattern of occurrence of psychiatric-like symptoms between sexes in an AD model. Our results also reveal that functional alterations in synapse activity appear as a potentially significant substrate underlying behavioural correlates of AD.


Assuntos
Doença de Alzheimer/patologia , Doença de Alzheimer/psicologia , Encéfalo/patologia , Modelos Animais de Doenças , Comportamento Social , Sinapses/patologia , Fatores Etários , Doença de Alzheimer/metabolismo , Doença de Alzheimer/fisiopatologia , Precursor de Proteína beta-Amiloide/metabolismo , Animais , Encéfalo/metabolismo , Encéfalo/fisiopatologia , Feminino , Humanos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Fatores Sexuais , Sinapses/metabolismo , Proteínas tau/metabolismo
20.
Sci Rep ; 2: 480, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22761989

RESUMO

Tau hyperphosphorylation is one hallmark of Alzheimer's disease (AD) pathology. Pharmaceutical companies have thus developed kinase inhibitors aiming to reduce tau hyperphosphorylation. One obstacle in screening for tau kinase inhibitors is the low phosphorylation levels of AD-related phospho-epitopes in normal adult mice and cultured cells. We have shown that hypothermia induces tau hyperphosphorylation in vitro and in vivo. Here, we hypothesized that hypothermia could be used to assess tau kinase inhibitors efficacy. Hypothermia applied to models of biological gradual complexity such as neuronal-like cells, ex vivo brain slices and adult non-transgenic mice leads to tau hyperphosphorylation at multiple AD-related phospho-epitopes. We show that Glycogen Synthase Kinase-3 inhibitors LiCl and AR-A014418, as well as roscovitine, a cyclin-dependent kinase 5 inhibitor, decrease hypothermia-induced tau hyperphosphorylation, leading to different tau phosphorylation profiles. Therefore, we propose hypothermia-induced hyperphosphorylation as a reliable, fast, convenient and inexpensive tool to screen for tau kinase inhibitors.


Assuntos
Avaliação Pré-Clínica de Medicamentos , Quinase 3 da Glicogênio Sintase/antagonistas & inibidores , Inibidores de Proteínas Quinases/farmacologia , Anestesia , Animais , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Linhagem Celular , Quinase 5 Dependente de Ciclina/antagonistas & inibidores , Quinase 5 Dependente de Ciclina/metabolismo , Feminino , Quinase 3 da Glicogênio Sintase/metabolismo , Hipotermia/induzido quimicamente , Hipotermia/enzimologia , Cloreto de Lítio/administração & dosagem , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Fosforilação/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...